Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
China · Delayed Price · Currency is CNY 3.820
-0.060 (-1.55%)
Sep 8, 2026, 3:04 PM CST
SHE:002198 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 125.23 | 164.65 | 336.14 | 135.21 | 185.74 | 242.89 |
Trading Asset Securities | 3.21 | 12.47 | - | 200.53 | 50.26 | - |
Cash & Short-Term Investments | 128.45 | 177.11 | 336.14 | 335.74 | 236 | 242.89 |
Cash Growth | -37.66% | -47.31% | 0.12% | 42.26% | -2.83% | 68.58% |
Accounts Receivable | 198.04 | 174.36 | 128.93 | 154.05 | 224.61 | 159.92 |
Other Receivables | 6.62 | 5.57 | 1.16 | 0.09 | 0.51 | -0.03 |
Receivables | 204.66 | 179.93 | 130.09 | 154.3 | 225.27 | 160.06 |
Inventory | 106.59 | 74.04 | 85.06 | 84.6 | 82.28 | 73.36 |
Prepaid Expenses | - | - | 0.01 | - | - | 0.17 |
Other Current Assets | 52.9 | 71.6 | 2.46 | 5.53 | 13.87 | 13.2 |
Total Current Assets | 492.6 | 502.68 | 553.76 | 580.17 | 557.43 | 489.67 |
Property, Plant & Equipment | 216.54 | 209.38 | 209.94 | 190.41 | 203.7 | 224.19 |
Long-Term Investments | 38.7 | 40.98 | 23.3 | 27.09 | 29.38 | 30.59 |
Other Intangible Assets | 48.83 | 45.91 | 45.89 | 47.21 | 52.37 | 58.29 |
Long-Term Deferred Tax Assets | 4.34 | 3.81 | 3.03 | 2.19 | 2.21 | 4.59 |
Long-Term Deferred Charges | 37.05 | 37.08 | 1.4 | - | - | - |
Other Long-Term Assets | 9.19 | 9.41 | 1.49 | 0.49 | 1.55 | - |
Total Assets | 847.26 | 849.23 | 838.82 | 847.56 | 846.65 | 807.34 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 23.36 | 26.86 | 12.61 | 9.16 | 18.98 | 14.12 |
Accrued Expenses | 2.58 | 14.45 | 12.94 | 21.35 | 21.06 | 16.52 |
Short-Term Debt | 20 | - | - | - | - | 31.11 |
Current Income Taxes Payable | 0.97 | 3.67 | 2.86 | 1.93 | 2.19 | 1.07 |
Current Unearned Revenue | 2.8 | 3.49 | 2.88 | 2.21 | 11.12 | 2.56 |
Other Current Liabilities | 57.77 | 47.92 | 14.28 | 14.7 | 29.6 | 22.54 |
Total Current Liabilities | 107.49 | 96.38 | 45.57 | 49.34 | 82.95 | 87.91 |
Long-Term Unearned Revenue | 0.14 | 0.17 | 0.29 | 0.41 | 0.54 | 0.2 |
Long-Term Deferred Tax Liabilities | 34.75 | 34.75 | 34.75 | 34.83 | 34.75 | 34.75 |
Total Liabilities | 142.38 | 131.3 | 80.6 | 84.58 | 118.23 | 122.85 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 507.51 | 507.51 | 507.51 | 507.51 | 507.51 | 507.51 |
Additional Paid-In Capital | 110.12 | 124.36 | 123.65 | 123.65 | 123.41 | 123.41 |
Retained Earnings | 144.56 | 157.54 | 127.06 | 131.82 | 97.5 | 53.57 |
Treasury Stock | -54.16 | -70 | - | - | - | - |
Comprehensive Income & Other | -3.15 | -1.48 | - | - | - | - |
Shareholders' Equity | 704.88 | 717.93 | 758.22 | 762.98 | 728.42 | 684.48 |
Total Liabilities & Equity | 847.26 | 849.23 | 838.82 | 847.56 | 846.65 | 807.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 20 | - | - | - | - | 31.11 |
Net Cash (Debt) | 108.45 | 177.11 | 336.14 | 335.74 | 236 | 211.78 |
Net Cash Growth | -47.37% | -47.31% | 0.12% | 42.26% | 11.44% | 70.91% |
Net Cash Per Share | 0.21 | 0.35 | 0.66 | 0.66 | 0.47 | 0.42 |
Filing Date Shares Outstanding | 377.72 | 497.11 | 507.51 | 507.51 | 507.51 | 507.51 |
Total Common Shares Outstanding | 377.72 | 497.11 | 507.51 | 507.51 | 507.51 | 507.51 |
Working Capital | 385.11 | 406.29 | 508.19 | 530.83 | 474.49 | 401.76 |
Book Value Per Share | 1.87 | 1.44 | 1.49 | 1.50 | 1.44 | 1.35 |
Tangible Book Value | 656.05 | 672.02 | 712.33 | 715.78 | 676.04 | 626.19 |
Tangible Book Value Per Share | 1.74 | 1.35 | 1.40 | 1.41 | 1.33 | 1.23 |
Buildings | - | 312.8 | 285.78 | 279.17 | 277.57 | 279.88 |
Machinery | - | 154.79 | 152.4 | 158.85 | 163.77 | 168.06 |
Construction In Progress | - | 16.75 | 29.06 | 1.66 | - | - |